2019亚洲日韩新视频_97精品在线观看_国产成人精品一区二区_91精品网站在线观看

Personalized Medicine

Personalized Medicine期刊基本信息

Personalized Medicine
  • 簡稱:PERS MED
  • 大類:醫(yī)學(xué)
  • 小類:藥學(xué)
  • ISSN:1741-0541
  • IF值:1.414
  • 周期:Quarterly
  • 是否SCI:SCIE
  • 是否OA:No
  • 出版地:ENGLAND
  • 平均錄用比例:較易
投稿咨詢

Personalized Medicine中文簡介

個性化醫(yī)學(xué)(ISSN 1741-0541)將最近基因組學(xué)、遺傳學(xué)和蛋白質(zhì)組學(xué)的進(jìn)展轉(zhuǎn)化為臨床應(yīng)用。該雜志為所有參與者提供了一個綜合論壇,包括學(xué)術(shù)和臨床研究人員、制藥公司、監(jiān)管機(jī)構(gòu)、醫(yī)療管理組織、患者組織和醫(yī)療行業(yè)的其他組織。個性化醫(yī)療通過提供一個專家評論和分析的平臺,幫助這些團(tuán)體塑造醫(yī)學(xué)的未來。該雜志涉及個性化醫(yī)療的科學(xué)、商業(yè)和政策問題,包括新聞和觀點(diǎn),對新生物標(biāo)志物的最新認(rèn)識,簡明的評論和分析,會議巡回報告和完整的綜述文章。提交給個性化醫(yī)療的文章必須經(jīng)過嚴(yán)格的同行審查。討論的主題包括:分子診斷的進(jìn)展;生物芯片/微陣列技術(shù);針對特定遺傳和免疫靶點(diǎn)的生物療法或疫苗方法;個性化醫(yī)療的成本效益問題;個性化醫(yī)療倫理;個性化醫(yī)療對醫(yī)療保健和制藥行業(yè)的影響基于藥物基因組學(xué)、藥物基因?qū)W和藥物蛋白質(zhì)組學(xué)的個性化藥物發(fā)展的最新概念的影響將遺傳分析納入臨床試驗(yàn)方法;診斷與治療相結(jié)合;藥物不良反應(yīng)及安全性預(yù)測治療監(jiān)測。

Personalized Medicine英文簡介

Personalized Medicine (ISSN 1741-0541) translates recent genomic, genetic and proteomic advances into the clinical context. The journal provides an integrated forum for all players involved - academic and clinical researchers, pharmaceutical companies, regulatory authorities, healthcare management organizations, patient organizations and others in the healthcare community. Personalized Medicine assists these parties to shape the future of medicine by providing a platform for expert commentary and analysis. The journal addresses scientific, commercial and policy issues in Personalized Medicine and includes news and views, current awareness regarding new biomarkers, concise commentary and analysis, reports from the conference circuit and full review articles. Articles submitted to Personalized Medicine are subject to rigorous peer review. Topics addressed include: Advances in molecular diagnostics; Biochip/microarray technologies; Biological therapies or vaccine approaches at specific genetic and immunologic targets; Cost-benefit issues for personalized medicine; Ethics in personalized medicine; Impact of personalized medicine on healthcare and the pharmaceutical industry; Impact of the latest concepts of development of personalized medicine based on pharmacogenomics, pharmacogenetics and pharmacoproteomics; Incorporation of genetic analysis in clinical trials methodology; Integration of diagnosis with therapy; Prediction of adverse reactions of drugs and drug safety; Treatment monitoring.

國際期刊推選 論文翻潤預(yù)審發(fā)表!

選擇豐富服務(wù)快速通過率高一鍵快速領(lǐng)取私人專屬發(fā)表方案!

* 請認(rèn)真填寫需求信息,學(xué)術(shù)顧問24小時內(nèi)與您取得聯(lián)系。

主站蜘蛛池模板: 丰顺县| 贵德县| 胶南市| 肥西县| 茌平县| 瑞金市| 会东县| 浪卡子县| 尼木县| 神池县| 浪卡子县| 大同县| 博罗县| 浪卡子县| 东台市| 罗定市| 鄯善县| 辽阳县| 沈丘县| 白玉县| 广东省| 彭阳县| 九江市| 科技| 大洼县| 香格里拉县| 安远县| 宁海县| 扎囊县| 句容市| 含山县| 康定县| 舞阳县| 龙井市| 哈尔滨市| 潜江市| 方城县| 香河县| 湘西| 漯河市| 曲麻莱县|